Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-01-25

FDA Approved: PIRFENIDONE — Original Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approved Accord Healthcare's generic pirfenidone as an original application for the treatment of idiopathic pulmonary fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PIRFENIDONE (pirfenidone)

Snippet

ORIG AP for PIRFENIDONE (PIRFENIDONE)